SCHEMBL27856421

SCHEMBL27856421

CC(C)(C)C(=O)ONCCCO

nearest known ligand 0.67

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 1/20 0.39
PTGS1 P23219 1/20 0.38
KCNH2 Q12809 1/20 0.38
CYP4F2 P78329 3/20 0.35
CYP4A11 Q02928 3/20 0.35
CNR2 P34972 2/20 0.33
PRKCA P17252 1/20 0.32
CNR1 P21554 1/20 0.31
ACHE P22303 6/20 0.30
ELANE P08246 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27541532 0.87 CNR2 (0.38) TDP1CNR2PRKCACNR1ELANE
Ammonia Solution, Strong SCHEMBL28029565 0.85 CNR2 (0.37) TDP1CNR2PRKCACNR1
SCHEMBL19611882 0.82
SCHEMBL28824126 0.80 EPHX1 (0.46) CNR2
SCHEMBL25328102 0.79 TDP1 (0.33) TDP1CNR2
SCHEMBL14378864 0.79 PAOX (0.46) TDP1
Ammonia Solution, Strong SCHEMBL28111373 0.79 EPHX1 (0.44) CNR2
SCHEMBL28184077 0.79 PAOX (0.46) TDP1
SCHEMBL28132626 0.79 GRM4 (0.31)
SCHEMBL28251787 0.79 KISS1R (0.36) PRKCA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102924390-B Synthetic method of 1,5-diazacyclooctane-1-tert-butyl ester formate SUZHOU KANGRUN PHARMACEUTICALS INC 2014-12-31 CN claimed
CN-106967066-B Novel ss-lactam enzyme inhibitor and preparation method thereof 明治制果药业株式会社 2019-07-30 CN disclosed
CN-105859609-B Beta-lactamase inhibitor and preparation method thereof 明治制果药业株式会社 2019-04-09 CN disclosed
CN-108727407-A Novel benzodiazepine * derivatives 伊缪诺金公司 2018-11-02 CN disclosed
CN-108295073-A Multi-fluorinated compounds are as bruton's tyrosine kinase inhibitor 浙江导明医药科技有限公司 2018-07-20 CN disclosed
CN-106061976-B Polyfluoro compounds as bruton's tyrosine kinase inhibitors 浙江导明医药科技有限公司 2018-05-15 CN disclosed
CN-106967066-A New beta lactamase restrainer and preparation method thereof 明治制果药业株式会社 2017-07-21 CN disclosed
CN-104910148-B Aminotriazole(ATA) and pyridine and its as kinase inhibitor purposes 西格诺药品有限公司 2017-06-27 CN disclosed
CN-106661084-A Macrocyclic broad spectrum antibiotics 阿奇克斯制药公司 2017-05-10 CN disclosed
CN-104334559-B Beta-lactamase inhibitor and preparation method thereof 明治制果药业株式会社 2017-03-22 CN disclosed
CN-102971325-B For reducing the compound that amyloid-beta produces BRISTOL-MYERS SQUIBB CO. (US) 2016-01-20 CN disclosed
CN-105198908-A Novel benzodiazepine derivatives IMMUNOGEN INC 2015-12-30 CN disclosed
CN-105175434-A NOVEL BENZODIAZEPINE DERIVATIVES IMMUNOGEN INC 2015-12-23 CN disclosed
CN-105017256-A Polyfluorinated compound Bruton tyrosine kinase inhibitor ZHEJIANG DAOMING PHARMACEUTICAL CO LTD 2015-11-04 CN disclosed
CN-104910148-A Aminotriazolopyridines and use thereof as kinase inhibitors SIGNAL PHARM LLC 2015-09-16 CN disclosed
CN-102365021-B Novel benzodiazepine derivatives IMMUNOGEN INC 2015-07-15 CN disclosed
CN-102203093-B Aminotriazolopyridines and their use as kinase inhibitors SIGNAL PHARM LLC 2015-05-13 CN disclosed
CN-104334559-A Novel beta-lactamase inhibitor and process for preparing the same MEIJI SEIKA PHARMA CO LTD 2015-02-04 CN disclosed
CN-102924390-B Synthetic method of 1,5-diazacyclooctane-1-tert-butyl ester formate SUZHOU KANGRUN PHARMACEUTICALS INC 2014-12-31 CN disclosed
CN-102365021-A Novel benzodiazepine derivatives IMMUNOGEN INC 2012-02-29 CN disclosed